DALLAS, Sept. 4, 2018 /PRNewswire/ -- WellBridge Healthcare is pleased to announce that Soni Helmickihas been appointed Chief Executive Officer of the WellBridge Hospital in Fort Worth. Ms. Helmicki is an esteemed behavioral health executive with extensive experience in the North Texas area.
"We are thrilled to have someone of Soni's capability, knowledge and experience to lead our hospital in Fort Worth," said Scott Wilson, Chairman. "Soni brings proven leadership and regional expertise to expand our successful inpatient and outpatient programs. She truly exemplifies our mission to be the best mental health provider in every community that we serve."
"I am motivated and honored to lead WellBridge Fort Worth. I look forward to building on our success and to continually improving services to meet the broader needs of our community. I have always had a passion for mental health and wellbeing, and I am delighted to continue serving the residents of Fort Worth and the surrounding communities," Helmicki said.
WellBridge Fort Worth is a behavioral health hospital offering a continuum of behavioral healthcare services, from inpatient beds to outpatient therapy for adults and seniors throughout the North Texas region.
ABOUT WELLBRIDGE HEALTHCARE
WellBridge Healthcare is a regional leader in behavioral health operating multiple inpatient and outpatient behavioral healthcare locations in Texas. Founded in 2014, WellBridge Healthcare provides innovative behavioral health services to senior and adult patients with a focus on treating cognitive and progressive mental health symptoms. For further information, visit www.wellbridgehealthcare.com
View original content:http://www.prnewswire.com/news-releases/behavioral-health-expert-soni-helmicki-named-chief-executive-officer-of-wellbridge-fort-worth-hospital-300706500.html
SOURCE WellBridge Healthcare
Subscribe to our Free Newsletters!
Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...View All